This section encompasses substances altering hormone activity or metabolism, including aromatase inhibitors, selective estrogen receptor modulators (SERMs), myostatin inhibitors, and metabolic regulators
Youles M, Holmes O, Petoukhov M V, Nessen M A, Stivala S, Svergun D I and Gherardi E (2008) Engineering the NK1 Fragment of Hepatocyte Growth Factor/Scatter Factor as a MET Receptor Antagonist, in Journal of Molecular Biology pp 616-622
Purchase requires valid medical licensure or institutional healthcare credential verification
VQ and plant audit ar Founded in 2007, Finetech is a high-tech enterprise focusing on the research and development, production and CDMO services of functional chemicals, KSMs, intermediates and APIs